MyFinsight
Home
Blog
About
Contact
Download
Download image
Net increase
(decrease) in cash and cash...
-$1,055K
Proceeds from notes
payable issued
$1,112K
Accounts payable and
accrued expenses
$1,873K
Accounts receivable
-$756K
Prepaid expenses and
other current assets
-$294K
Change in fair value of
conversion feature...
-$235K
Amortization of discount of
notes payable and...
$164K
Loss on debt
extinguishment
-$76K
Other non-current
assets
-$30K
Depreciation and
amortization
$15K
Change in fair value of
warrant derivative...
-$2K
Share-based compensation
$1K
Net cash flows used
in financing...
-$702K
Net cash flows used
in operating...
-$344K
Effect of exchange rate
changes on cash
-$9K
Canceled cashflow
$1,112K
Canceled cashflow
$3,446K
Payments of notes payable
$1,796K
Net loss
-$3,335K
Payments of convertible
notes
$9K
Payments of notes
payable, related party
$9K
Inventories
$351K
Operating lease
liabilities
-$77K
Foreign exchange
adjustments
$22K
Inventory reserve
$4K
Other liabilities
-$1K
Back
Back
Cash Flow
Emmaus Life Sciences, Inc. (EMMA)
Emmaus Life Sciences, Inc. (EMMA)
source: myfinsight.com